Allkem - OROCF Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allkem in the last year. There are currently 2 sell ratings, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OROCF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OROCF, but not buy additional shares or sell existing shares.
View OROCF analyst ratings or view top-rated stocks.

Allkem's stock was trading at $7.50 at the start of the year. Since then, OROCF stock has increased by 17.7% and is now trading at $8.8250.
View the best growth stocks for 2022 here.

Allkem saw a drop in short interest in November. As of November 15th, there was short interest totaling 569,700 shares, a drop of 30.5% from the October 31st total of 819,600 shares. Based on an average daily volume of 116,500 shares, the short-interest ratio is presently 4.9 days.
View Allkem's Short Interest.

Allkem trades on the OTCMKTS under the ticker symbol "OROCF."

Shares of OROCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OROCF stock can currently be purchased for approximately $8.83.

Allkem (OTCMKTS:OROCF) has a market capitalization of $3.04 billion and generates $769.82 million in revenue each year.

The company employs 1,300 workers across the globe.

Allkem's mailing address is Riparian Plaza Level 35 71 Eagle Street, Brisbane C3, QLD 4000. The official website for the company is www.orocobre.com. The company can be reached via phone at (173) 064-3600, via email at abarber@orocobre.com, or via fax at 61-7-3720-8988.